Home › Biogen Idec and Sobi Announce European Medicines Agency Validates...
 

Keywords :   


Biogen Idec and Sobi Announce European Medicines Agency Validates...

2014-10-31 22:14:45| Appliances - Topix.net

CAMBRIDGE, Mass. & STOCKHOLM-- -- Biogen Idec and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has validated the Marketing Authorization Application of ELOCTAa , a recombinant factor VIII Fc fusion protein product candidate for the treatment of hemophilia A. The validation of the MAA initiates the EMA's review process.

Tags: agency european announce medicines

Category:Consumer Goods and Services

Latest from this category

All news
26.11Sports service SPOTV adopts Zixi for affiliate delivery
26.11EQT to sell Melita to Goldman Sachs Alternatives
26.11U.S. spending on standalone pay TV increased in Q3 2024
26.11DIRECTV terminates agreement to acquire EchoStar's DISH
26.11Xumo and PubMatic partner on programmatic advertising
26.11Vauxhall owner to close Luton plant
26.11Adara solves PowerKEY CA time-out issue for Aster Tecnodisa
26.11Mediaocean to acquire Innovid
Consumer Goods and Services »
26.11BG
26.11 DVD 9
26.11Happy2024 LAST BIG
26.111-21
26.11A-68507
26.11160cm
26.11stray kids GO yes24
26.11 mark borthwick whats bummer zine edition
More »